Skip to content

Frontline
AI News
Jobs
Sectors

Frontline
AI News
Jobs
Sign in

Live sectors

Coming soon

Loading

Frontline
AI News
Jobs
Sectors

Frontline
AI News
Jobs
Sign in

Live sectors

Coming soon

Loading

Medtronic competitors — companies like Medtronic in Neuromodulation & Stimulation · fobi

Frontline
AI News
Jobs
Sectors

- Blockchain / Crypto
- Cloud & Edge Computing
- Cybersecurity
- Data Infrastructure
- Digital Identity
- Payments & Financial Infrastructure

Frontline
AI News
Jobs
Sign in

Live sectors

Coming soon

Medtronic competitors

6 other companies on the FOBI brain-computer interfaces roster in Neuromodulation & Stimulation

NeuroPace
NPCE
Develops the RNS System, a responsive neurostimulation device that detects and treats epileptic seizures in real time.
Neuromodulation & Stimulation · IPO $105.2M
Neuromodulation & Stimulation
IPO
$105.2M
HQ
Compare side-by-side →
Motif Neurotech

Develops magnetoelectric neural stimulation technology for non-invasive, deep-brain modulation targeting psychiatric and neurological disorders.
Neuromodulation & Stimulation · Series A $18.8M
Neuromodulation & Stimulation
Series A
$18.8M
HQ
Compare side-by-side →

For subscribers

Subscribe to see all 6 competitors

4 more brain-computer interfaces companies in Neuromodulation & Stimulation, plus side-by-side comparison links into the rest of the roster.

Already subscribed? Sign in →

Neuroelectrics

Develops non-invasive transcranial electrical stimulation and EEG systems for research and clinical applications in epilepsy and neurorehabilitation.
Neuromodulation & Stimulation · Series A $17.5M
Neuromodulation & Stimulation
Series A
$17.5M
HQ
Compare side-by-side →
Flow Neuroscience

Produces a transcranial direct current stimulation headset for at-home treatment of depression, combined with behavioral therapy.

Editorial analysis, not financial advice.

Theme

Send feedback

Goes straight to my inbox. No auto-replies, no tickets.

What's this about?

General feedbackSomething's brokenFeature ideaContent / data issue

Feedback

Email (optional — only if you want a reply)

Website

Reviewed weekly.

More▾

FAQ
What's new
Disclosures
Terms
Privacy
Usage policy

© 2026 fobi

Editorial analysis, not financial advice.·FAQ·What’s new

Neuromodulation & Stimulation · Series A $9.3M

Neuromodulation & Stimulation

Series A

$9.3M

HQ

Compare side-by-side →

Offers spinal cord stimulation, dorsal root ganglion stimulation, and deep brain stimulation systems for chronic pain and movement disorders.

Neuromodulation & Stimulation · Public

Neuromodulation & Stimulation

Compare side-by-side →

Boston Scientific

Provides spinal cord stimulation and deep brain stimulation devices for chronic pain, Parkinson's disease, and essential tremor.

Neuromodulation & Stimulation · Public

Neuromodulation & Stimulation

Compare side-by-side →

·

·

·

·

·

© 2026 fobi

Theme

Send feedback

Goes straight to my inbox. No auto-replies, no tickets.

What's this about?

General feedbackSomething's brokenFeature ideaContent / data issue

Feedback

Email (optional — only if you want a reply)

Website

Reviewed weekly.

Founding

50% off

$5

/month

91 of 100 spots left

Full

$10

/month

Available once all 100 Founding Member spots are claimed.

Get full access